HomeInsightsResults

Torrent Pharmaceuticals Ltd Quarterly Result

Torrent Pharmaceuticals Ltd Quarterly Result

stocks purchased

₹ 1.2 Cr

Volume Transacted

(Dec 20, 2024)

stocks purchased

3.4 K

Stocks Traded

(Dec 20, 2024)

Last Updated on: Dec 23, 2024

Image

Torrent Pharmaceuticals Ltd

NSE: TORNTPHARM

Net Profit

₹ 453

Last updated on: Dec 23, 2024

Key Highlights

  • The revenue of Torrent Pharmaceuticals Ltd for the Sep '24 is ₹ 2873 crore as compare to the Jun '24 revenue of ₹ 2883 crore. This represent the decline of -0.34686092%.
  • The ebitda of Torrent Pharmaceuticals Ltd for the Sep '24 is ₹ 923 crore as compare to the Jun '24 ebitda of ₹ 928 crore. This represent the decline of -0.5387931%.
  • The net profit of Torrent Pharmaceuticals Ltd for the Sep '24 is ₹ 453 crore as compare to the Jun '24 net profit of ₹ 457 crore. This represent the decline of -0.8752735%.

Results Analysis

Market Price of Torrent Pharmaceuticals Ltd

1M

1Y

3Y

5Y

Monitoring Torrent Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
20 Dec 20243434.25
19 Dec 20243467.25
18 Dec 20243380.25
17 Dec 20243380
16 Dec 20243360.4
13 Dec 20243347.65
12 Dec 20243328.25
11 Dec 20243374.3
10 Dec 20243348.35
09 Dec 20243335.85

Historical Revenue of Torrent Pharmaceuticals Ltd

No data available

* All values are in crore

Historical EBITDA of Torrent Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Net Profit of Torrent Pharmaceuticals Ltd

No data available

* All values are in crore

Torrent Pharmaceuticals Ltd News Hub

News

Torrent Pharmaceuticals Ltd up for fifth session

Torrent Pharmaceuticals Ltd is up for a fifth straight session in a row. The stock is quot...

Read more

19 Dec 2024 13:00

News

Torrent Pharma to acquire three anti-diabetes brands from Boehringer Ingelheim

The brands include Cospiaq (empagliflozin), Cospiaq Met (empagliflozin + metformin) and Xi...

Read more

05 Dec 2024 12:19

News

Torrent Pharmaceuticals Ltd soars 1.44%, up for third straight session

Torrent Pharmaceuticals Ltd rose for a third straight session today. The stock is quoting ...

Read more

03 Dec 2024 13:06

News

Torrent Pharma gets penalty of Rs 2.32 cr from Income Tax Department

'Based on the company assessment, the company will pursue an appeal and is hopeful of favo...

Read more

29 Nov 2024 12:51

News

Torrent Pharmaceuticals Ltd spurts 1.59%, rises for third straight session

Torrent Pharmaceuticals Ltd rose for a third straight session today. The stock is quoting ...

Read more

25 Nov 2024 13:05

News

Torrent Pharma rises as Pithampur unit gets VAI classification

The United States Food and Drug Administration (USFDA) conducted inspection at Pithampur m...

Read more

22 Nov 2024 12:45

Document

Annual Reports

Annual Report 2024

dropdown
download

Credit Ratings

Credit Report 2024

dropdown
download

Concalls

July 2024

Transcript

May 2024

Transcript

Feb 2024

Transcript

Aug 2023

Transcript

May 2023

Transcript

Sep 2022

PPT

May 2021

Transcript

Feb 2021

Transcript

Oct 2020

Transcript

July 2020

Transcript

May 2020

Transcript

FAQs for Quarterly Results of Torrent Pharmaceuticals Ltd

What key financial metrics are included in Torrent Pharmaceuticals Ltd's quarterly results?

Key financial metrics in Torrent Pharmaceuticals Ltd's quarterly results typically include revenue, net profit, earnings per share (EPS), and operating margins. Other metrics might include cash flow, operating expenses, and client metrics.

When does Torrent Pharmaceuticals Ltd announce its quarterly results?

Torrent Pharmaceuticals Ltd usually announces its quarterly results around mid-July for Q1, mid-October for Q2, mid-January for Q3, and mid-April for Q4, aligning with the end of each fiscal quarter. However, different finance companies have their respective schedules for announcing their quarterly results.

How does Torrent Pharmaceuticals Ltd's quarterly performance impact its stock price?

Torrent Pharmaceuticals Ltd's quarterly performance can lead to stock price volatility, with strong results often driving the price up, while disappointing results can cause it to drop. Investor sentiment and market expectations also play significant roles.

What is the impact of Torrent Pharmaceuticals Ltd's quarterly results on dividends?

The impact of Torrent Pharmaceuticals Ltd's quarterly results on dividends can influence dividend decisions, with strong performance potentially leading to increased or special dividends, while weaker results might result in stable or reduced dividends.

Are there any special announcements usually made during Torrent Pharmaceuticals Ltd's quarterly results?

Yes, Torrent Pharmaceuticals Ltd often makes special announcements during its quarterly results, including strategic updates, key client wins, and major contract renewals. They might also guide future performance and share insights on industry trends. These updates are typically highlighted in their press release. However, special announcements made during quarterly results may vary from company to company.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions